Altis Labs to Develop Digital Twins for Clinical Trials in Partnership with Leading Research Institutions and Global Biopharmaceutical Companies
Altis Labs announces today that it is leading an international coalition focused on the development and implementation of digital twins in clinical trials.
Lactiga Receives FDA ‘Rare Pediatric Disease’ Designation for Groundbreaking Mucosal Immunoglobulin Therapy for CVID
LCTG-001 on course to be the first FDA-approved biologic from human milk for pediatric patients with Common Variable Immunodeficiency.